Loading insider details...
Latest Form 4 (Nov 4, 2026): Sale of 46,609 TAK shares, $973.7K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 4, 2026 | TAKEDA PHARMACEUTICAL CO LTD (TAK) | Sale | 46,609 | $973.7K |
| Aug 13, 2026 | TAKEDA PHARMACEUTICAL CO LTD (TAK) | Sale | 50,012 | $855.2K |
| Jul 6, 2026 | TAKEDA PHARMACEUTICAL CO LTD (TAK) | Grant/Award | 43,886 | n/a |
| Jun 15, 2026 | Aura Biosciences, Inc. (AURA) | Grant/Award | 15,000 | n/a |
| Apr 28, 2026 | TAKEDA PHARMACEUTICAL CO LTD (TAK) | Grant/Award | 64,988 | n/a |
| Apr 2, 2025 | Aura Biosciences, Inc. (AURA) | Grant/Award | 21,000 | n/a |
| Jun 4, 2024 | Fusion Pharmaceuticals Inc. (FUSN) | Disposition to Issuer | 34,000 | n/a |